Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor software version update with no observable changes to the study details.SummaryDifference0.1%

- Check10 days agoChange DetectedGlossary is now shown on the page; update metadata now includes 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3 with no changes to study content or essential features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedLocations section updated to include Guangdong and Hubei locations; revision noted as v3.3.3.SummaryDifference0.4%

- Check74 days agoChange DetectedRevision: v3.3.2 is now shown, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government funding/operating status notice was removed from the page, an administrative update that does not affect the trial’s core content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.